Nanobiotix (NBTX) Long-Term Investments (2018 - 2025)

Nanobiotix's (NBTX) quarterly Long-Term Investments came in at $505194.9 in Q4 2025, up 16.44% year-on-year from $433849.7 in Q4 2024, and up 9.12% quarter-over-quarter from $462971.5 in Q2 2025.

Nanobiotix (NBTX) Long-Term Investments (2018 - 2025) Analysis & Trends

Nanobiotix's Long-Term Investments history runs 8 years deep, the most recent figure standing at $505194.9 for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 16.44% year-over-year to $505194.9 in Q4 2025; TTM through Dec 2025 was $505194.9, a 16.44% increase from a year earlier, with the FY2025 full-year figure at $490338.1, up 13.02% from the prior year.
  • Long-Term Investments rose to $505194.9 in Q4 2025 per NBTX's latest filing, from $462971.5 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $599727.2 in Q2 2021 and bottomed at $296892.0 in Q4 2022.
  • The 5-year median for Long-Term Investments is $404726.8 (2022), against an average of $424149.1.
  • Across the five-year window, Long-Term Investments slumped 49.99% in 2022 and soared 39.58% in 2025, its largest moves.
  • Year by year, Long-Term Investments stood at $593720.9 in 2021, then tumbled by 49.99% to $296892.0 in 2022, then increased by 8.36% to $321706.0 in 2023, then surged by 34.86% to $433849.7 in 2024, then rose by 16.44% to $505194.9 in 2025.
  • Per Business Quant, the three latest NBTX Long-Term Investments figures stand at $505194.9 (Q4 2025), $462971.5 (Q2 2025), and $433849.7 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 505,194.89
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 22.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 505,194.89
Jun 30, 2025 462,971.51
Dec 31, 2024 433,849.73
Jun 30, 2024 331,681.37
Dec 31, 2023 321,706.03
Jun 30, 2023 320,143.77
Dec 31, 2022 296,891.98
Jun 30, 2022 375,603.95
Dec 31, 2021 593,720.92
Jun 30, 2021 599,727.18
Dec 31, 2020 602,106.37
Dec 31, 2019 585,543.58
Dec 31, 2018 636,899.21